Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:


Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

Sorrento Reports Positive Topline Results from China Trial of COVID Therapy 

WestVac Biopharma Approved to Launch COVID-19 Vaccine for XBB Variants

Clover Launches COVID-19 Vaccine in China as Second Booster Dose

Junshi Bio’s NDA for COVID-19 Therapy Accepted for Review in China

WestGene Biopharma Completes $21 Million Funding for mRNA Drugs

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital